Lv51
880 积分 2023-12-09 加入
Adverse events associated with gepants: a pharmacovigilance analysis based on the FDA adverse event reporting system
7小时前
已完结
Patient-derived Immunocompetent Tumor Organoids: A Platform for Chemotherapy Evaluation in the Context of T-cell Recognition
18天前
已完结
Gastrointestinal adverse events associated with SNRIs: A FAERS-based pharmacovigilance study
25天前
已完结
New Insight on the Safety of Erenumab: An Analysis of Spontaneous Reports of Adverse Events Recorded in the US Food and Drug Administration Adverse Event Reporting System Database
28天前
已完结
Efficacy and safety of finotonlimab plus docetaxel vs. docetaxel in previously treated advanced squamous cell non-small-cell lung cancer: a randomized, double-blinded, phase III trial
1个月前
已完结
Ocular adverse events associated with GLP-1 receptor agonists: a Real-World Study Based on the FAERS database and network pharmacology
1个月前
已完结
The real-world safety profile of pemetrexed and platinum with or without pembrolizumab: insights from a comparative analysis of FAERS database
1个月前
已完结
Adverse drug reaction assessment of pembrolizumab in cervical cancer treatment: a real-world pharmacovigilance study using the FAERS database
2个月前
已完结
A Drug Similarity-Based Bayesian Method for Early Adverse Drug Event Detection
2个月前
已完结
A real-world pharmacovigilance study of netarsudil based on the FDA adverse event reporting system (FAERS)
2个月前
已关闭
皖公网安备34019202002308
